Idiotype-pulsed dendritic cells are able to induce antitumoral cytotoxic CD8 cells in chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 120, Issue 2, 2003, Pages 243-250

  Vuillier, Françoise ^a   Maloum, Karim ^b   Thomas, Elaine K ^c   Magnac, Christian ^a   Dumas, Gérard ^a   Payelle Brogard, Béatrice ^a   Oppezzo, Pablo ^a   Dighiero, Guillaume ^a   Scott Algara, Daniel ^a  

^a INSTITUT PASTEUR   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c AMGEN INC   (United States)

Author keywords

Chronic lymphocytic leukaemia; Cytotoxic CD8; Dendritic cell; Idiotype

Indexed keywords

CD28 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN IDIOTYPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; CELL MATURATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; DISEASE COURSE; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR CELL;

ANTIGENS, CD; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; LEUKEMIA, B-CELL, CHRONIC; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0037272708     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04075.x     Document Type: Article

References (33)

1. Bannerji, R. & Byrd, J.C. (2000) Update on the biology of chronic lymphocytic leukemia. Current Opinion in Oncology, 12, 22-29.
2. Bendandi, M., Gocke, C.D., Kobrin, C.B., Benko, F.A., Sternas, L.A., Pennington, R., Watson, T.M., Reynolds, C.W., Gause, B.L., Duffey, P.L., Jaffe, E.S., Creekmore, S.P., Longo, D.L. & Kwak, L.W. (1999) Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nature Medicine, 5, 1171-1177.
3. Bojarska-Junak, A., Rolinski, J., Wasik-Szczepaneko, E., Kaluzny, Z. & Dmoszynska. A. (2002) Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia. Haematologica, 87, 490-499.
4. Buhmann, R., Nolte, A., Westhaus, D., Emmerich, B. & Hallek, M. (1999) CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells. Blood. 93, 1992-2002.
5. Caligaris-Cappio, F. & Hamblin, T.J. (1999) B-cell chronic lymphocytic leukemia: a bird of a different feather. Journal of Clinical Oncology, 17, 399-408.
6. Champagne, P., Ogg, G.S., King, A.S., Knabenhans, C., Ellefsen, K., Nobile, M., Appay, V., Rizzardi, G.P., Fleury, S., Lipp, M., Forster, R., Rowland-Jones, S., Sekaly, R.P., McMichael, A.J. & Pantaleo. G. (2001) Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature, 410, 106-111.
7. Chaux, P., Vantomme, V., Coulie, P., Boon, T. & van der Bruggen. P. (1998) Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer. International Journal of Cancer, 77, 538-542.
8. Cull, G., Durrant, L., Stainer, C., Haynes, A. & Russell, N. (1999) Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma. British Journal of Haematology, 107, 648-655.
9. Dighiero, G. & Binet, J.L. (2000) When and how to treat chronic lymphocytic leukemia. New England Journal of Medicine, 343, 1799-1801.
10. Dumas, G., Pritsch, O., Pereira, A., Gallart, T. & Dighiero, G. (1997) A murine model of human cold agglutinin disease. British Journal of Haematology, 98, 589-596.
11. Goddard, R.V., Prentice, A.G., Copplestone, J.A. & Kaminski, E.R. (2001) Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate. Clinical and Experimental Immunology, 126, 16-28.
12. Granziero, L., Ghia, P., Circosta, P., Gottardi, D., Strola, G., Geuna, M., Montagna, L., Piccoli, P., Chilosi, M. & Caligaris-Cappio, F. (2001) Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood, 97, 2777-2783.
13. Gricks, C.S., Rawlings, E., Foroni, L., Madrigal, J.A. & Amlot, P.L. (2001) Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells. Cancer Research, 61, 5145-5152.
14. He, X.S., Rehermann, B., Lopez-Labrador, F.X., Boisvert, J., Cheung, R., Mumm, J., Wedemeyer, H., Berenguer, M., Wright, T.L., Davis, M.M. & Greenberg, H.B. (1999) Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proceedings of the National Academy of Sciences of the United States of America, 96, 5692-5697.
15. Hislop, A.D., Gudgeon, N.H., Callan, M.F., Fazou, C., Hasegawa, H., Salmon, M. & Rickinson, A.B. (2001) EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function. Journal of Immunology, 167, 2019-2029.
16. Hsu, F.J., Benike, C., Fagnoni, F., Liles, T.M., Czerwinski, D., Taidi, B., Engleman, E.G. & Levy, R. (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Medicine, 2, 52-58.
17. Hsu, F.J., Caspar, C.B., Czerwinski, D., Kwak, L.W., Liles, T.M., Syrengelas, A., Taidi-Laskowski, B. & Levy, R. (1997) Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma: long-term results of a clinical trial. Blood, 89, 3129-3135.
18. Kwak, L.W., Campbell, M.J., Czerwinski, D.K., Hart, S., Miller, R.A. & Levy, R. (1992) Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. New England Journal of Medicine, 327, 1209-1215.
19. Matutes, E., Owusu-Ankomah, K., Morilla, R., Garcia Marco, J., Houlihan, A., Que, T.H. & Catovsky, D. (1994) The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia, 8, 1640-1645.
20. Mosca, P.J., Hobeika, A.C., Clay, T.M., Nair, S.K., Thomas, E.K., Morse, M.A. & Lyerly, H.K. (2000) A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment. Blood, 96, 3499-3504.
21. Nelson, E.L., Li, X., Hsu, F.J., Kwak, L.W., Levy, R., Clayberger, C. & Krensky, A.M. (1996) Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma. Blood, 88, 580-589.
22. Osterroth, F., Carbe, A., Fisch, P. & Veelken, H. (2000) Stimulation of cytotoxic T cells against idiotype immunoglobulin of malignant lymphoma with protein-pulsed or idiotype-transduced dendritic cells. Blood, 95, 1342-1349.
23. Pritsch, O., Magnac, C., Dumas, G., Egile, C, & Dighiero, G. (1993) V gene usage by seven hybrids derived from CD5+ B-cell chronic lymphocytic leukemia and displaying autoantibody activity. Blood, 82, 3103-3112.
24. Reid, D.C. (2001) Dendritic cells and immunotherapy for malignant disease. British Journal of Haematology, 112, 874-887.
25. Rezvany, M.R., Jeddi-Tehrani, M., Rabbani, H., Lewin, N., Avila-Carino, J., Osterborg, A., Wigzell, H. & Mellstedt, H. (2000) Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia. British Journal of Haematology, 111, 608-617.
26. Rezvany, M.R., Jeddi-Tehrani, M., Biberfeld, P., Soderlund, J., Mellstedt, H., Osterborg, A. & Rabbani, H. (2001) Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern. British Journal of Haematology, 115, 263-271.
27. Sallusto, F. & Lanzavecchia, A. (2001) Exploring pathways for memory T cell generation. Journal of Clinical Investigation, 108, 805-806.
28. Shimoni, A., Marcus, H., Dekel, B., Shkarchi, R., Arditti, F., Shvidel, L., Shtalrid, M., Bucher, W., Canaan, A., Ergas, D., Berrebi, A. & Reisner, Y. (1999) Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human → mouse radiation chimera. Cancer Research, 59, 5968-5974.
29. Staveley-O'Carroll, K., Sotomayor, E., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D. & Levitsky, H. (1998) Induction of antigen-specific T cell anergy: an early event in the course of tumor progression. Proceedings of the National Academy of Sciences of the United States of America, 95, 1178-1183.
30. Titzer, S., Christensen, O., Manzke, O., Tesch, H., Wolf, J., Emmerich, B., Carsten, C., Diehl, V. & Bohlen, H. (2000) Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects. British Journal of Haematology, 108, 805-816.
31. Trojan, A., Schultze, J.L., Witzens, M., Vonderheide, R.H., Ladetto, M., Donovan, J.W. & Gribben, J.G. (2000) Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies. Nature Medicine, 6, 667-672.
32. Vuillier, F., Maloum, K., Thomas, E.K., Jouanne, C., Dighiero, G. & Scott-Algara, D. (2001) Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemia. British Journal of Haematology, 115, 831-844.
33. Wen, Y.J., Min, R., Tricot, G., Barlogie, B. & Yi, Q. (2002) Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy. Blood, 99, 3280-3285.